StonvexLoading…
StonvexStonvexStonvexCore line items from AMWL's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $54.88M | $249.32M | $194.02M | $137.73M |
Operating Income | $-17.42M | $-105.27M | $-80.12M | $-50.79M |
Net Income | $-10.89M | $-95.70M | $-70.78M | $-38.40M |
EPS (Diluted) | $-0.66 | $-5.96 | $-4.44 | $-2.43 |
Total Assets | $325.97M | $323.79M | $359.43M | $388.66M |
Total Liabilities | $85.84M | $76.00M | $92.06M | $94.08M |
Cash & Equivalents | $179.21M | $182.33M | $200.89M | $219.07M |
Free Cash Flow OCF − CapEx | $-988.00K | $-65.97M | $-48.61M | $-29.84M |
Shares Outstanding | 16.66M | 16.43M | 16.32M | 16.09M |